AbsEn.i
Analysis
new
Racine
Analysis
new
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars) - Analysis (new)

Index « AbsEn.i » - entrée « ace »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
accurately < ace < aceis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000043 (2020) H Y Tian [République populaire de Chine][2019-nCoV: new challenges from coronavirus].
000077 (2020) Xian Peng ; Xin Xu ; Yuqing Li ; Lei Cheng ; Xuedong Zhou ; Biao RenTransmission routes of 2019-nCoV and controls in dental practice
000092 (2020) Robert L. Kruse [États-Unis]Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000151 (2020) Junwen Luan [République populaire de Chine] ; Yue Lu [République populaire de Chine] ; Xiaolu Jin [République populaire de Chine] ; Leiliang Zhang [République populaire de Chine]Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
000154 (2020) Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000182 (2020) Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
000199 (2020) Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis]Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
000221 (2020) Tao Zhang [République populaire de Chine] ; Qunfu Wu [République populaire de Chine] ; Zhigang Zhang [République populaire de Chine]Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.
000244 (2020) Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine]Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
000312 (2020) Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis]Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
000324 (2020) J L Olds [États-Unis] ; N. Kabbani [États-Unis]Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?
000331 (2020) Muh-Yong Yen [Taïwan] ; Jonathan Schwartz [États-Unis] ; Shey-Ying Chen [Taïwan] ; Chwan-Chuen King [Taïwan] ; Guang-Yang Yang [Taïwan] ; Po-Ren Hsueh [Taïwan]Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts.
000352 (2020) James H. Diaz [États-Unis]Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
000365 (2020) David S. Fedson [Oman] ; Steven M. Opal [États-Unis] ; Ole Martin Rordam [Norvège]Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.
000540 (2020) Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis]Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
000566 (2020) George ThomsonCOVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond?
000643 (2020) Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000771 (2009) Masaru Iwai ; Masatsugu HoriuchiDevil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i -k "ace" 

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i  \
                -Sk "ace" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    ace
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021